Search

You searched for "complaints"

1035 results found

Are social media promoting ocular protection in the community?

3 June 2024 | | Ophthalmology, COVID-19
During the Covid-19 pandemic, many countries worldwide introduced lockdown measures to control infection, causing people to spend more time at home. This resulted in reports of increasing incidences of do-it-yourself (DIY)-related trauma. When the Covid-19 pandemic started in December 2019,...

Traumatic injuries from foam Nerf bullets

5 June 2023 | | Emergency Ophthalmology, Paediatric Ophthalmology / Strabismus
Background Three patients are presented in this case report: an adult and two children which were subjected to ocular injuries from Nerf gun bullets. Generally, Nerf guns are considered safer than airsoft guns. While there are many papers on airsoft...

Upper eyelid ulceration as a presenting sign of frontal sinus mucocele

3 October 2022 | | Ophthalmology
Introduction A sinus mucocele is an epithelium-lined sac filled with mucus and desquamated epithelium. It forms secondary to inflammatory processes that occur in a sinus with an obstructed ostium. Predisposing conditions include previous trauma, surgery, tumours, anatomical abnormalities, and chronic...

Minimally Invasive Glaucoma Surgery: What options are there and when might they be considered?

25 March 2024 | | Glaucoma, ONLINE EXCLUSIVE ARTICLES
In recent years there has been a rapid expansion in a group of operations termed ‘minimally invasive’ or ‘micro invasive’ glaucoma surgery (MIGS). These options generally offer less significant IOP reduction, but with a more favourable safety profile when compared...

My Top Five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | AMD
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

My Top Five: Uses of artificial intelligence in ophthalmology

3 August 2023 | | Ophthalmology
Artificial Intelligence (AI) has emerged as a prominent topic of discussion within the field of ophthalmology, captivating researchers and practitioners alike. Although recent attention has been drawn to the integration of AI in ophthalmology, it’s important to recognise that AI...

Reflections on a twelve-year partnership: The Makassar-Dundee LINK

3 June 2021 | | Ophthalmology, Paediatric Ophthalmology / Strabismus, COVID-19
In the first article of a two-part series (see Part 2 here), the authors provide an overview of this hugely successful partnership and how they overcame the challenges of COVID-19. What began in 2008 as a connection between equals, has...

Ocular manifestations of multiple sclerosis: an overview

1 December 2022 | | Ophthalmology, Genetics
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS), in which there is dissemination of lesions in time (two or more clinical events) and space (multiple lesions seen on brain and spinal imaging). The pathophysiology...

Stem cell transplantation and pterygium surgery

28 November 2022 | | Ophthalmology
Pterygium is a benign, fibrovascular overgrowth of bulbar conjunctiva extending onto the cornea and has been associated with ultraviolet (UV) light exposure. The prevalence of pterygium worldwide varies between geographical zones but has been reported to range between three and...

FAQs about cerebral visual impairment (CVI): identifying and helping those affected

2 August 2022 | | Ophthalmology
Cerebral visual impairment is common in both adults and children, yet the diagnosis can easily be missed unless one is tuned into the presenting features. This article provides a succinct introduction to this important topic. What is vision? Vision is...

Working smarter not harder: How to transform eyecare delivery in the United Kingdom (part 2)

1 February 2022 | | Ophthalmology, Optometry
Are we doing enough to meet the current demands on ophthalmic services? In part two of a two-part series (see Part 1 here), Rosalind Harrison explains how efficiency can be improved by setting up eye services in community hubs. The...

Gene therapy for inherited retinal disease: the Manchester Ocular Gene Therapy Group MDT service

4 August 2021 | | Ophthalmology, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
The authors describe the process set up in Manchester for the optimum delivery and assessment of a new gene therapy treatment for patients with RPE65 IRD. Inherited retinal dystrophies (IRDs) are the second commonest cause of severe visual impairment in...